Navigation Links
BioLife Solutions and SAVSU Technologies Announce Exclusive Distribution Agreement
Date:9/23/2013

BOTHELL, Wash. and SANTE FE, N.M., Sept. 23, 2013 /PRNewswire/ -- BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media products for cells and tissues, and contract aseptic media manufacturer, and SAVSU Technologies, Inc., a subsidiary of Barson Corporation, today jointly announced an agreement wherein BioLife will exclusively market and distribute SAVSU's proprietary precision thermal packaging products to the stem cells and regenerative medicine markets.

Mike Rice, BioLife Solutions President and CEO, stated, "This agreement represents another step to expand our best-in-class biopreservation tools portfolio.  SAVSU's precision thermal packaging products ensure temperature stability that is another important element in the continuum of biologistics of precious human cells and tissues. This partnership will expand opportunities for BioLife to help our customers further optimize and improve the critical yield and cost dynamics of transporting biologic source materials and manufactured cell and tissue products within a required and validated temperature range."

The regenerative medicine market is expected to grow to more than $35 billion by 2019, according to TriMark Publications' recently published "Regenerative Medicine Markets" report.  BioLife's addressable portion of the market is the demand for reagents and precision thermal packaging products used to store, ship and freeze source material and manufactured doses of cell-based products and therapies.

Bruce McCormick, President & CEO of SAVSU Technologies, commented, "We are very pleased to appoint BioLife as our exclusive distributor to the stem cells and regenerative medicine markets.  Our products are highly complementary and the BioLife team has demonstrated remarkable success in achieving market adoption of novel biopreservation tools.  We look to BioLife to present our value proposition at scientific conferences and to consult with their customers to enable an even more robust performance and quality profile of cell and tissue based products and therapies."

SAVSU's reusable, cost-effective, precision thermal packaging products offer superior temperature stability, extreme durability, and an interior payload volume customizable for relevant source material and final manufactured dose form factors used in the stem cells and regenerative medicine markets.

BioLife Solutions and SAVSU representatives will be presenting the combined product offering at the following upcoming conferences:

Stem Cells & Regenerative Medicine Conference
September 30 – October 1, 2013
Hyatt Regency, Cambridge, MA

GDP & Temperature Management Logistics Global Forum
September 30 – October 4, 2013
Hyatt Regency McCormick Place, Chicago, IL

About SAVSU Technologies
SAVSU® designs and builds solutions to ensure the safe delivery and storage of medicines and biologics used to provide global health. Our mission is to improve global health by greatly reducing the waste and risks associated with the improper freezing and overheating of thermal-sensitive medicines and biologics. SAVSU® has developed proprietary state-of-the-art technology to ultimately lower costs and improve delivery of these most essential materials.  For more information please visit www.savsu.com.

About BioLife Solutions
BioLife Solutions develops, manufactures and markets hypothermic storage and cryopreservation solutions for cells, tissues, and organs.  The Company's proprietary HypoThermosol® and CryoStor® platform of biopreservation media products are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife's products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death.  BioLife's enabling technology provides academic and clinical researchers significant improvement in shelf life and post-preservation viability and function of cells, tissues, and organs.  BioLife Solutions is certified to ISO13485:2003. For more information please visit www.biolifesolutions.com, and follow BioLife on Twitter.

This news release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995.  These forward-looking statements include any statements that relate to the intent, belief, plans or expectations of the Company or its management, or that are not a statement of historical fact.  Any forward-looking statements in this news release are based on current expectations and beliefs and are subject to numerous risks and uncertainties that could cause actual results to differ materially. Some of the specific factors that could cause BioLife Solutions' actual results to differ materially are discussed in the Company's recent filings with the Securities and Exchange Commission.  BioLife Solutions disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this press release. Media & Investor RelationsDaphne TaylorSenior Vice President, Chief Financial Officer(425) 686-6002 dtaylor@biolifesolutions.com
'/>"/>

SOURCE BioLife Solutions, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioLife Solutions Announces the Addition of Robert Preti, Ph.D. to its Scientific Advisory Board
2. BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress
3. BioLife Solutions Announces 2012 Full Year Results; 10th Consecutive Quarter of Record Revenue
4. BioLife Solutions Appoints Rick Stewart To Board of Directors
5. BioLife Solutions Completes First $1 Million Revenue Quarter
6. inVentiv Clinical Trial Recruitment Solutions Partners with Pioneering Firm to Revolutionize Clinical Trial Site Evaluation
7. MR Solutions to Launch Two World Firsts in Pre Clinical Scanning at the World Molecular Imaging Conference in Savannah This Week - a Combined 3T, Cryogen Free MRI/PET and a 3T MRI/SPECT
8. OstoSolutions Invites Ostomates to Join "Make A Change Day" in Celebration of Ostomy Awareness Day 2013
9. Metabolic Solutions Development Company presents Phase 2a clinical trial results at the 14th International Conference on Alzheimers Drug Discovery
10. Sound World Solutions Expands Distribution Of The CS10 Personal Sound Amplifier
11. mHealth Apps & Solutions Market Worth $20.7 Billion by 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will ... at the Sheraton Hotel in Toronto, Ontario . ... Company is scheduled to present on Tuesday, May 2 at 10:00 ... of the Board, Tony Holler will also attend the ... For more details about ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
(Date:4/19/2017)... BOSTON , April 19, 2017  New research provides ... with advanced Parkinson,s, according to a study released today that ... 69th Annual Meeting in Boston , ... comes to the treatment of Parkinson,s disease, the oral drug ... of life and longevity. But as the disease progresses, the ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... ... Intellitec Solutions announced the publication of a case study ... solution that integrates to their PointClickCare EHR software package. With the guidance of ... now has the capability to achieve its goal for a comprehensive EHR solution, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Semrock’s highly popular SearchLight ... online modeling resource for fluorescence microscopists and optical system designers, enabling The Right ... years spanning the globe, SearchLight has become a tremendously popular tool for the ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... Healthcare companies ... But they will rapidly reject an outdated healthcare executive resume. , “If you’re a ... at your executive resume and wondering if it’s as ready as you are for ...
(Date:4/27/2017)... ... April 27, 2017 , ... SyncDog, ... sponsorship at MobileIron Live! 2017 in Santa Clara, California. Each year, ... educational approach to helping organizations maximize the benefits of mobility in their operations ...
(Date:4/27/2017)... ... April 27, 2017 , ... Plastic Surgery Associates is excited to ... to present at the upcoming Aesthetic Meeting. Held in San Diego, at the San ... and Canales will lend their expertise to the Premier Global Hot Topics session, speaking ...
Breaking Medicine News(10 mins):